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Abstract
Impairments in neuro and social cognition are considered core features of schizophrenia
(SCZ) since they affect patients’ functioning and contribute to poor socio-occupational out-
comes. Therefore, the improvement of cognitive performances has become a primary goal
in the care of patients with SCZ, especially in the first phases of the disease, as early interven-
tions may favour better long-term outcomes. Cognitive remediation (CR) is a behavioural
training aimed at improving cognitive functions with the goal of durability and generalisation
in everyday life. Neuroimaging studies suggest that CR leads to neuroplasticity in chronic SCZ,
whereas only a few studies tested the neural effects of CR in the early phase of the disease.
Thus, in this review, we aimed at summarising CR-induced structural and functional brain
changes in early SCZ. Existing evidence showed a protective effect of CR on grey matter
volume in selected medial-temporal (i.e. hippocampus, parahippocampus and amygdala)
and thalamic regions whereas functional changes affected mostly dorsolateral prefrontal
and insular cortices both associated with improvements in cognitive performance and emo-
tion regulation. Overall, CR in early SCZ appears to be associated with neural adaptations
mostly allocated in prefrontal and limbic regions, however future longitudinal studies are
needed to clarify whether the positive effects of cognitive training persist over time. It may
also be interesting to investigate whether the application of CR in the early v. the late stage
of the disease may lead to incremental benefits.
Schizophrenia (SCZ) is a chronic psychiatric disorder characterised by marked cognitive
impairments that affect functional ability, predict poor interpersonal and socio-occupational
outcomes and appears associated with structural and functional brain changes in this popula-
tion (Green et al., 2004; Barch and Ceaser, 2012). Since cognitive deficits of patients with SCZ
respond only moderately to pharmacotherapy, in the last 15 years, researchers have focused on
behavioural interventions aimed at improving the patient’s functioning in everyday life such as
cognitive remediation (CR) (Wykes et al., 2011). A growing number of studies showed durable
effects of CR on cognition and global functioning as well as a positive effect on neural activity
of patients with chronic SCZ (Wykes et al., 2011; Penadés et al., 2017). Conversely, only a pau-
city of neuroimaging studies investigated the effect of CR in early SCZ and results are still
sparse (Eack et al., 2010, 2016; Keshavan et al., 2017; Ramsay et al., 2017). Given that brain
changes occurring in SCZ appear to worsen over time (Torres et al., 2016), the application
of CR in the early phase of the disease may play a crucial role in protecting against future
neural alteration and its subsequent impact on cognitive abilities and functioning.
In this review, we aimed to describe neuroimaging studies that investigated the effect of CR
on brain structures and activity in patients with SCZ in the early phase of the disease.
The bibliographic search was performed using PUBMED and Web of Science databases.
The following keywords were used for the search: (cognitive) AND (remediation OR training
OR rehabilitation) AND (early OR first episode) AND (psychosis OR schizophrenia) AND
(magnetic resonance imaging). The inclusion criteria are: (i) original publication published
in a peer-reviewed journal, (ii) English language, (iii) the use of a structured protocol for
CR training, (iv) the inclusion of a comparison group undergoing a control therapy and (v)
application of structural or functional neuroimaging techniques. After title and abstract
screening, four studies were identified and included in the review, three of which used the
same cohort of patients (Eack et al., 2010, 2016; Keshavan et al., 2017). Methodological char-
acteristics and main findings from each study are shown in Table 1.
Ramsay et al. (2017) conducted a structural magnetic resonance imaging (MRI) study to
test the effect of a CR training v. a control therapy, on grey matter volumes of patients with
early SCZ (Ramsay et al., 2017). After 40 h of training, the CR group showed larger thalamus
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Table 1. Neuroimaging studies of CR in early SCZ
Reference
Number
of participants
(M/F)
Age
(mean
± S.D.)
Years of
illness
(mean ± S.D.)
Diagnosis
(n)
CR
intervention Intervention length
Imaging
method Main results
Ramsay
et al. (2017)
CR: 43 (31/12)
CT: 43 (33/10)
21.70 ± 3.26
20.74 ± 3.37
1.57 ± 1.30
1.68 ± 1.45
SCZ (ns)
SAD (ns)
AT 40 h/8–10 weeks sMRI (3T) CR v. CT showed larger GM thalamic volumes
after the training. L thalamus GM volumes
correlated positively with cognitive performance.
Findings suggest that the cognitive gains induced
by CR are associated with structural
neuroplasticity in the thalamus.
Keshavan
et al. (2017)
CR: 25 (14/11)
CT: 16 (12/4)
24.95 ± 5.16
26.13 ± 5.29
3.36 ± 2.45
2.97 ± 1.84
SCZ (26)
SAD (15)
CET 60 h/3 months ( + 45
weekly sessions of
social-cognitive group)
fMRI (3T) CR v. CT showed increased activity in the R dlPFC
activation and reduced connectivity between
dlPFC and ACC. Increased R dlPFC activity
correlated positively with neurocognitive
improvements.
Eack et al.
(2016)
CR: 25 (14/11)
CT: 16 (12/4)
29.95 ± 5.16
26.13 ± 5.29
3.36 ± 2.45
2.97 ± 1.84
SCZ (25)
SAD (16)
CET 60 h/3 months ( + 45
1.5 h weekly sessions of
social-cognitive group)
rsfMRI (3T) CR v. CT showed greater functional connectivity
preservation between the resting-state networks
involved in emotion processing and problem
solving (i.e. fronto-temporal network) and the L
dlPFC and increased connectivity between the
fronto-temporal network and the R insula.
In patients treated with CR increased insular and
L dlPFC connectivity correlated with improved
emotion perception and regulation, respectively.
Eack et al.
(2010)
CR: 31 (ns) CT: 27
(ns)
26.17 ± 6.51 3.22 ± 2.2 SCZ (53)
SAD (18)
CET 60 h/3 months ( + 45
1.5 h weekly sessions of
social-cognitive group)
sMRI (3T) CR v. CT showed greater preservation of GM
volume in the L hippocampus, parahippocampal,
fusiform gyrus and L amygdala GM volume
increases. Volumetric changes were associated
with improved cognition.
ACC, anterior cingulate cortex; AT, auditory training cognitive remediation; BOLD, blood-oxygenation level dependent; CET, cognitive enhancement therapy; CR, cognitive remediation; CT, control therapy; dlPFC, dorsolateral prefrontal cortex; F, females;
fMRI, functional magnetic resonance imaging; GM, grey matter; L, left; M, males; ns, not specified; R, right; SCZ, schizophrenia; SAD, schizoaffective disorder; rsfMRI, resting state functional magnetic resonance imaging; sMRI, structural magnetic
resonance imaging; T, tesla.
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than the control group. Moreover, within the CR group, left thal-
amus correlated positively with changes in cognitive performance
(Ramsay et al., 2017). Additional three neuroimaging studies were
conducted in early SCZ, by using the same sample of patients ran-
domly assigned to a CR training (i.e. cognitive enhancement ther-
apy –CET), or enriched supportive therapy (EST) and treated for
two years (Eack et al., 2010, 2016; Keshavan et al., 2017). In the
first study by Eack et al. (2010) patients undergoing CET showed
greater preservation of grey matter volume over the course of 2
years in the left hippocampus, parahippocampal gyrus and fusi-
form gyrus, and greater grey matter increases in the left amygdala
than those receiving EST. Lower grey matter loss in the left
parahippocampus and fusiform gyrus was significantly associated
with improved neuro and social cognition, while greater grey mat-
ter increases in the left amygdala was associated with improved
social cognition suggesting that amygdala may play a key role in
social-cognitive processes (e.g. perspective-taking) (Lamm et al.,
2007).
In a second study, Eack et al. (2016) examined the effects of
CET on frontotemporal brain connectivity, using resting-state
functional MRI (Eack et al., 2016). Compared to the control
group, patients treated with CET showed lower reduction of the
left dorsolateral prefrontal cortex (dlPFC) connectivity and
increased right insula connectivity with the resting state network.
Moreover, within the CET group, increases in the connectivity
between the right insula and the left dlPFC were associated
with improvements in emotion perception and regulation,
respectively (Eack et al., 2016).
In the third study, the authors aimed at exploring longitudinal
changes in brain activations and connectivity in the CET v. EST
group, and the association with performances at cognitive tasks
(Keshavan et al., 2017).
Patients treated with CET exhibited a continuous increase of
neural activity in the right dlPFC, that was associated with mod-
erate improvements in neurocognition, suggesting a potential
neuroprotective effect of CET. By contrast, patients treated with
EST revealed a progressive reduction of task-related neural activa-
tion. Moreover, functional connectivity analysis showed decreases
in connectivity between the dlPFC and the anterior cingulate cor-
tex (ACC) in CET compared to EST over the two years of treat-
ment, which was associated with neurocognitive improvement.
Conversely, patients treated with EST showed no changes in func-
tional connectivity over time (Keshavan et al., 2017).
Overall, available MRI studies in patients with early SCZ sug-
gest that CR interventions are associated with structural and func-
tional brain changes mostly allocated in frontal and limbic regions
(i.e. hippocampus, amygdala, dlPFC and ACC) (Eack et al., 2010,
2016; Keshavan et al., 2017; Ramsay et al., 2017). In particular, CR
appears to decelerate or partially reverse progressive brain volume
deterioration occurring in the early phases of illness in areas
known to be crucial for higher-order cognitive processes, includ-
ing the frontal cortex, thalamus, hippocampus and the amygdala
(Eack et al., 2010; Ramsay et al., 2017). Consistently, CR seems to
have a ‘normalising’ effect on resting-state networks and func-
tional activity in the frontotemporal network, amygdala and
ACC of patients with early SCZ (Eack et al., 2016; Keshavan
et al., 2017). Moreover, neuroplastic changes associated with CR
in early SCZ correlated with improvements in neuro and social
cognition in all the presented studies (Eack et al., 2010, 2016;
Keshavan et al., 2017; Ramsay et al., 2017). It is plausible that
these ameliorations can be obtained by increasing or decreasing
signalling in neural circuits (Penadés et al., 2017).
Even though CR effects in early SCZ resemble those observed
in chronic patients, we can speculate that the neuroprotective
effect of CR could be the highest the earliest the intervention is
offered, as in the early phase of illness neurodevelopmental pro-
cesses are still taking place (Corbera et al., 2017). Moreover,
early interventions proved to be effective in reducing negative
symptoms and increasing socio-occupational functioning in
SCZ (Bond et al., 2015; Murru and Carpiniello, 2018). Thus,
given the efficacy of early interventions in other domains of
SCZ, it is also plausible that intervening on cognitive impairments
in the early stages of SCZ may lead to a better long-term func-
tional outcome and possibly have a protective effect against neural
alterations associated with the pathology.
To conclude, CR appears to be a promising approach in the
treatment of cognitive deficits and neural alterations associated
with the early phase of SCZ. However, evidence is still sparse,
as only a paucity of studies has been conducted with limited con-
trol for confounding factors (e.g. heterogeneous patients’ popula-
tions and methodology). Particularly, the long-term effect of CR
interventions on brain plasticity has not been investigated yet.
As such, future studies (using multimodal techniques) are needed
to assess whether CR may be considered a sustainable approach
with long-lasting positive effects on cognitive and neural altera-
tions of patients with SCZ. Particularly, we warrant the conduct
of longitudinal studies starting from the very early stage of the ill-
ness to clarify whether the application of CR in the early v.
chronic phase of the disease may have incremental benefits.
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